Results 241 to 250 of about 429,152 (298)

Efficacy and safety of empagliflozin for treating neutropenia and neutrophil dysfunction in paediatric patients with glycogen storage disease type Ib: A systematic review and meta‐analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Glycogen storage disease type Ib (GSD‐Ib) is a rare genetic disorder causing neutropenia and neutrophil dysfunction in children. G‐CSF has been the primary treatment, but emerging data support the potential of empagliflozin, an SGLT2 inhibitor, as a promising investigational option.
Elizabeth Iwasyk   +5 more
wiley   +1 more source

Cronkhite-Canada Syndrome: A Diagnostic Challenge and Management With Vedolizumab. [PDF]

open access: yesAm J Case Rep
Nasirishargh A   +5 more
europepmc   +1 more source

Eating behaviour and nutritional status of children with mental illness. [PDF]

open access: yesJ Family Med Prim Care
Deka C   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy